SAXONOV SERGE (Chief Executive Officer) sold 0.9% of their position (9.63K shares) of 10X GENOMICS, INC. on the open market
Open‑market sale worth $178.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/25/2026ACC: 0001610717-26-000070
DirectorOfficer10% Owner· Chief Executive Officer
Since Sep 2019
-9.63K
Net shares
Net seller
$178.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.63K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−9.63K
Price / share
$18.58
Trade value
$178.93K
% of position
0.9%
2/23/2026
1.07M→1.06M
Total
Net shares
−9.63K
Net value
-$178.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/23/2026 | S · Sale | −9.63K | $18.58 | $178.93K | 0.9% | 1.07M | 1.06M |
| Total | −9.63K | -$178.93K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Class A Common Stock
IndirectShares owned27.00
Class A Common Stock
IndirectShares owned213.25K
Class A Common Stock
IndirectShares owned58K
Total
271.28K indirect271.28K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 27.00 | Indirect |
| Class A Common Stock | 213.25K | Indirect |
| Class A Common Stock | 58K | Indirect |
| Total | 271.28K | 271.28K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported